Login
Toggle navigation
Videos
Categories
Trending
Dr Stuart Quin, CEO of Medica Group PLC
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr Stuart Quin, CEO of Medica Group PLC, discusses the Group's first-half performance
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Unveiling SEI: A Diverse Vision for Financial Growth | Ryan Hicke, CEO , SEI Investments Company.
00:10:00
Interview with Stephen Yet: Perry Stone Natural Resource Fund at the One-to-One Mining Conference
00:10:00
Teaching Frederick Douglass's 'What to the Slave Is the Fourth of July?|Vincent Lloyd,Professor,Villanova University
00:10:00
Chargeurs CEO Michael Fribourg Discusses Quarterly Results on BFM Business | Michaël Fribourg - CEO of Chargeurs
00:10:00
Invests globally and has offices in California, Israel, India, and China|Nicholas Brathwaite,Founder and Managing Partner,Celesta (fka WRVI)
00:10:00
Brazilian Telecommunications Firm Charts Course for Global Expansion and 5G Technology Domination | Carlos Raimar, CEO, Padtec Holding.
00:10:00
Alligator Energy Unveils Continued High-Grade Uranium Findings in Samphire Resource Extension | Alligator Energy Ltd CEO Greg Hall
00:10:00
Steering Toward Sustainable Profitability After Near Bankruptcy | Calin Rovinescu, CEO, Air Canada.
00:10:00
The Company through its subsidiaries provides investment management and advisory services.|Tim Collins,CEO,Ripplewood Holding
00:10:00
Modeling Canada's Water Cycle for Climate Adaptation
00:10:00
Exploring Leadership and Success: Paul Singer, Founder and Co-CEO of Elliott Management, in Conversation with David Rubenstein
00:10:00
Advice and Insights from a Veteran CEO at a 95-Year-Old Company